Literature DB >> 8570131

Extended resections of ductal pancreatic cancer--impact on operative risk and prognosis.

J Klempnauer1, G J Ridder, H Bektas, R Pichlmayr.   

Abstract

114 patients received a standard and 75 patients an extended resection of ductal pancreatic carcinoma at the Hanover Medical School, Germany, from 1971 until 1993. Standard pancreatic resections were combined with vascular resection and reconstruction in 46 and additional organ resections in 45 cases. Vascular resections affected the mesentericoportal vein in 37, the common hepatic in 10 and the superior mesenteric artery in 7 cases. Pancreas resections were combined with total gastrectomy in 23, partial colectomy in 17, hemihepatectomy in 14, adrenalectomy in 8 and nephrectomy in 5 patients. Curative resections could be accomplished in 86% of patients without and 81% with extended resections. Additional vascular resections neither increased the operative risk nor deteriorated the long-term prognosis after resection. Additional organ resections, however, significantly increased the risk of lethality and impaired the long-term prognosis. Especially resections of synchronous hepatic metastases and colectomies were associated with a poor survival probability.

Entities:  

Mesh:

Year:  1996        PMID: 8570131     DOI: 10.1159/000227534

Source DB:  PubMed          Journal:  Oncology        ISSN: 0030-2414            Impact factor:   2.935


  18 in total

1.  Extended pancreatic resections and lymphadenectomy: An appraisal of the current evidence.

Authors:  Shailesh V Shrikhande; Savio G Barreto
Journal:  World J Gastrointest Surg       Date:  2010-02-27

2.  Pancreatic resection for pancreatic cancer.

Authors:  Jeannine Bachmann; Christoph W Michalski; Marc E Martignoni; Markus W Büchler; Helmut Friess
Journal:  HPB (Oxford)       Date:  2006       Impact factor: 3.647

Review 3.  Oligometastatic Disease in Pancreatic Cancer - How to Proceed?

Authors:  Bernhard W Renz; Stefan Boeck; Falk Roeder; Christoph Trumm; Volker Heinemann; Jens Werner
Journal:  Visc Med       Date:  2017-02-10

4.  Does anyone survive pancreatic ductal adenocarcinoma? A nationwide study re-evaluating the data of the Finnish Cancer Registry.

Authors:  M Carpelan-Holmström; S Nordling; E Pukkala; R Sankila; J Lüttges; G Klöppel; C Haglund
Journal:  Gut       Date:  2005-03       Impact factor: 23.059

5.  Extended pancreatectomy as defined by the ISGPS: useful in selected cases of pancreatic cancer but invaluable in other complex pancreatic tumors.

Authors:  Abhishek Mitra; Esha Pai; Rohit Dusane; Priya Ranganathan; Ashwin DeSouza; Mahesh Goel; Shailesh V Shrikhande
Journal:  Langenbecks Arch Surg       Date:  2018-01-23       Impact factor: 3.445

6.  A pancreatic anaplastic carcinoma of spindle-cell form.

Authors:  T Uenishi; K Hirohashi; S Kubo; H Hamba; T Ikebe; T Yamamoto; H Tanaka; K Wakasa; T Haba; H Kinoshita
Journal:  Int J Pancreatol       Date:  1999-12

7.  Resectable pleomorphic giant cell carcinoma of the pancreas.

Authors:  T Yamamoto; K Hirohashi; H Tanaka; T Uenishi; T Shuto; S Kubo; H Kinoshita
Journal:  Int J Pancreatol       Date:  2001

Review 8.  [Oligometastasis in pancreatic cancer : Current state of knowledge and spectrum of local therapy].

Authors:  F Gebauer; A I Damanakis; C Bruns
Journal:  Chirurg       Date:  2018-07       Impact factor: 0.955

9.  [Reconstruction of visceral arteries with homografts in excision of the pancreas].

Authors:  U Settmacher; J M Langrehr; I Husmann; R Eisele; M Bahra; M Heise; P Neuhaus
Journal:  Chirurg       Date:  2004-12       Impact factor: 0.955

10.  Portal vein resection in surgery for cancer of biliary tract and pancreas: special reference to the relationship between the surgical outcome and site of primary tumor.

Authors:  Isao Kurosaki; Katsuyoshi Hatakeyama; Masahiro Minagawa; Daisuke Sato
Journal:  J Gastrointest Surg       Date:  2007-10-30       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.